Loading
Endoplasmic Reticulum Stress and Disease · Journal article
Theoretical and Natural Science · August 17, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review examining the molecular mechanisms by which cancer cells exploit unfolded protein response (UPR) signaling to survive, metastasize, and resist therapy. The review proposes that UPR-driven survival, metastasis, and therapy resistance are interconnected manifestations of a unified stress adaptation strategy, but presents no new experimental evidence or clinical data to support efficacy of potential UPR-targeted interventions.
Journal article.
UPR is a homeostatic protective mechanism activated in response to ER stress that becomes co-opted by cancer cells to regulate tumor progression Three canonical UPR branches establish persistent adaptive state under chronic ER stress UPR signaling maintains proteostasis, reprograms cellular metabolism, alleviates oxidative stress, and coordinates autophagy to support cancer cell survival
Review does not evaluate efficacy or safety of specific UPR-targeted therapeutic interventions
The source did not state who this applies to in practice.
This is a narrative review synthesizing mechanistic understanding of how cancer cells exploit UPR signaling; it raises questions about therapeutic opportunity rather than testing efficacy in a clinical or experimental design.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
The unfolded protein response (UPR) is a homeostatic protective mechanism activated in response to endoplasmic reticulum (ER) stress. However, once co-opted by cancer cells, its function extends far beyond maintaining proteostasis and becomes an important regulator of tumor progression. This review summarizes how the three canonical UPR branches establish a persistent adaptive state under chronic ER stress. It discusses the molecular mechanisms by which UPR signaling maintains proteostasis, reprograms cellular metabolism, alleviates oxidative stress, and coordinates autophagy. Thereby it allows cancer cells to survive in hostile microenvironments. The review further examines how these adaptive programs support tumor metastasis by promoting anoikis resistance, epithelial-mesenchymal plasticity, and tumor dormancy, which also enhances resistance to chemotherapy and immunotherapy. Current evidence suggests that cancer cell survival, metastasis, and therapy resistance are not independent consequences of UPR activation, but interconnected manifestations of a unified stress adaptation strategy driven by the UPR. By clarifying how cancer cells exploit UPR signaling and its underlying mechanisms, this review aims to provide insights into potential specific therapeutic opportunities for cancer.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.